Free Trial
NASDAQ:APDN

Applied DNA Sciences Q3 2025 Earnings Report

Applied DNA Sciences logo
$2.94 +0.07 (+2.44%)
Closing price 09/19/2025 04:00 PM Eastern
Extended Trading
$2.94 +0.00 (+0.17%)
As of 08:52 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Applied DNA Sciences EPS Results

Actual EPS
-$34.00
Consensus EPS
-$37.50
Beat/Miss
Beat by +$3.50
One Year Ago EPS
N/A

Applied DNA Sciences Revenue Results

Actual Revenue
$0.30 million
Expected Revenue
$1.28 million
Beat/Miss
Missed by -$976.00 thousand
YoY Revenue Growth
N/A

Applied DNA Sciences Announcement Details

Quarter
Q3 2025
Time
Before Market Opens
Conference Call Date
Thursday, August 14, 2025
Conference Call Time
4:00PM ET

Applied DNA Sciences Earnings Headlines

Earnings Scheduled For August 26, 2025
Out of 18,347 Cryptocurrencies... This is the ONLY One
This Crypto Could Thrive as Global Tensions Rise Right as capital begins to rotate back into crypto, my top Fall 2025 pick sits at the center of it all...tc pixel
Applied DNA Sciences Focuses on LineaRx for Growth
Applied DNA Sciences Regains Nasdaq Compliance
Applied DNA Sciences, Inc. (APDN) - Yahoo Finance
See More Applied DNA Sciences Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Applied DNA Sciences? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Applied DNA Sciences and other key companies, straight to your email.

About Applied DNA Sciences

Applied DNA Sciences (NASDAQ:APDN), Inc. is a biotechnology company that specializes in the development and commercialization of DNA-based molecular technologies for product authentication, supply chain security, and anti-counterfeiting. Its proprietary SigNature® DNA taggants enable manufacturers and brand owners to embed unique, synthetic DNA markers into raw materials or finished goods, providing an immutable method of verifying origin and authenticity. This molecular tagging approach is designed to deter counterfeiting, diversion and the illicit resale of high-value products across a variety of end markets.

The company’s product portfolio includes SigNature® DNA solutions for pharmaceuticals, cosmetics, electronics and luxury goods, as well as SnapChain™ technology for cotton traceability. SnapChain™ offers a scalable way to certify fiber authenticity in textiles, helping retailers and consumers track the provenance of garments and raw materials. In addition to its tagging platforms, Applied DNA Sciences supplies molecular biology reagents—such as Helix Taq™ DNA polymerase—and offers contract laboratory services for forensic and diagnostic applications.

Headquartered in Stony Brook, New York, Applied DNA Sciences serves a global customer base spanning North America, Europe and Asia-Pacific. Its technologies address growing regulatory and consumer demands for transparency and integrity in supply chains, particularly in industries at high risk for counterfeit or diverted goods. Strategic partnerships with manufacturers, logistics providers and government agencies underpin the company’s efforts to expand adoption of its authentication platforms.

Under the leadership of President and Chief Executive Officer James A. Hayward, Applied DNA Sciences continues to innovate in molecular tagging and diagnostics. The company pursues both direct sales of its DNA solutions and licensing agreements with established supply-chain participants, aiming to extend its reach into new sectors such as agriculture, food safety and critical infrastructure protection.

View Applied DNA Sciences Profile

More Earnings Resources from MarketBeat